Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option
This study is enriched for large R-AMLs and uniquely focuses on CBA women. It reinforces the notion that most large R-AMLs are treated asymptomatically and do not necessarily represent the bleeding risk historically ascribed to them. It suggests that CBA woman status alone should not motivate R-AML treatment.
Authors
- Mark Dawidek (ORCID: https://orcid.org/0000-0003-2261-0857)
- Lennert Eismann (ORCID: https://orcid.org/0000-0002-9971-4411)
- Juan Sebastián Arroyave (ORCID: https://orcid.org/0009-0003-9480-0657)
- Paul Russo (ORCID: https://orcid.org/0000-0001-7487-6783)
- Irina Ostrovnaya (ORCID: https://orcid.org/0000-0003-1783-0070)
- Marc Ganz (ORCID: https://orcid.org/0009-0000-7610-1463)
- Karim A. Touijer
- Lina Posada Calderon
- Katiana Vazquez-Rivera
- A Ari Hakimi
- Fourat Ridouani (ORCID: https://orcid.org/0000-0003-2582-464X)
- Jonathan Coleman (ORCID: https://orcid.org/0000-0002-6428-7835)
- Hannah E. Fuchs (ORCID: https://orcid.org/0000-0003-2426-0096)
- Stephen W. Reese (ORCID: https://orcid.org/0000-0002-7486-0674)
Institutions
- Maimonides Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- SUNY Downstate Health Sciences University (US)
- Cornell University (US)
- Presbyterian Hospital (US)
- Mount Sinai Hospital (US)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1097/upj.0000000000000756
- Primary Topic
- Tuberous Sclerosis Complex Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00